Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by DJDawgon Dec 01, 2022 6:43pm
174 Views
Post# 35144816

RE:RE:RE:RE:RE:CG Oncology NMIBC data

RE:RE:RE:RE:RE:CG Oncology NMIBC data
One thing I find confusing is the duration of these various protocols. They go for quite a long time?

I noticed that for the immunity bio protocol they get treatements up until 18 m out. Interesting to see how the graph looks the further you go. They started with 82 patients. Then 58 achieve CR. Then 27 months later they are down to 21 patients. So 25% of the original 82. But check out the step drop down at 27 months. I have always felt that these immune therapy protocols are not curative if the disease comes back once you stop all your instillations for a bit. That drop off at 27 months is not promising for the longer term. I wonder when they will publish more.

<< Previous
Bullboard Posts
Next >>